🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨Our call to action to acknowledge brain fog as a significant public health issue is now published in BMC Series Public Health. 🔗doi.org/10.1186/s12889… ✍️We justify brain fog as a significant public health issue ❓ Provide 4 key questions to enhance our understanding and

Recognising brain fog as a significant public health concern - Darren Haywood Dr. Darren Haywood Professor Susan Ross Nicolas Hart oncodaily.com/blog/brain-fog… #Cancer #CancerResearch #Medicine #Health #MedX #MedNews #MedEd #HealthCare #PublicHealth #BrainFog #Oncology #OncoDaily

So much confusion about reliability versus validity when it comes to psychiatric diagnosis. Because of the way DSM is set up, I could conceivably take some symptoms of Disorder X, some symptoms of Disorder Y, combine them, and if these disorders co-occur with some frequency,

Reminder: Our call for papers on transdiagnostic approaches in neuropsychology with JCEN is open! Letters of intent are due in a few days—you don't need to have results finalised yet, just let us know you're interested! think.taylorandfrancis.com/special_issues…

🚨Check out our new paper recently published in the Journal of Psychopathology and Clinical Science led by 🦋 @jaicarmichael.bsky.social We argue that HiTOP has significant potential in clinical practice but to facilitate its wider clinical translation it must be presented as

New Viewpoint in the Journal of Psychopathology and Clinical Science on the use of the term “normal” in the DSM over time. It’s increasing, and it’s an unclear term. I found the discussion of this fascinating. Check it out. psycnet.apa.org/record/2026-12…

A real pleasure to spend more time with Dr Andrea Smith discussing our collective work on (and Andrea’s lived experience with) metastatic cancer survivorship, with the pre-eminent Bogda Koczwara on her #SupportiveCareMatters oncology podcast: oncologynews.com.au/clinical-focus…

Extremely honoured to be promoted to Professor at UTS. I’ve been blessed with excellent mentors over my career, and grateful to have incredible colleagues who I rely on heavily. And I am most thankful to my parents (and Baxter 🐕) for their unconditional love and support.

Now available! 📒 The Updated COSA Guidelines for the Psychosocial Management of Adolescents and Young Adults (AYAs) Diagnosed with Cancer. Very proud to have contributed to this Guideline by leading the update of the Post-Acute Psychosocial Care, and the Uncertainties

Congratulations to Dr. Darren Haywood for winning the MASCC Emerging Investigator Award (UTS Health) at the #MASCC25 conference. Thoroughly deserved for excellent work through the Cognition Fellowship, developing the MASCC COG-IMPACT Tool: mascc.org/resources/asse…

So proud to be awarded the MASCC Emerging Investigator Award! MASCC has been central to my work over the past 2 years, providing a welcoming and supportive environment for ECRs. A special thank you to my MASCC mentors and collaborators, particularly Nicolas Hart

This week in Seattle, at the MASCC / ISOO Annual meeting, I had the pleasure of presenting the work that was central to my MASCC Cognition Fellowship; the development and validation of the MASCC COG-IMPACT. The MASCC COG-IMPACT is the first and only unmet needs

Pleased to have COSA endorsement of the MASCC and ASCO Standards and Practice Recommendations for Advanced or Metastatic Cancer Survivorship Care: onlinelibrary.wiley.com/doi/epdf/10.11…. In this editorial, we offer implementation and future optimal care considerations.

🙅‍♂️ Every year, a meaningful proportion of people with a cancer diagnosis refuse suggested conventional cancer treatments. These individuals generally have more rapid deterioration and premature death. It is vital to understand the behavioural motivations of people who refuse

#ICYMI, our Psychosocial Study Group recently released a white paper summarizing issues relating to the experience of work after a cancer diagnosis through a global lens. Download for free: mascc.org/wp-content/upl… This project was supported to MASCC by Allianz Trade

Congratulations to Dr. Darren Haywood, the recipient of the 2025 Emerging Investigator Award. Dr. Haywood has been a standout contributor to MASCC projects across multiple study groups, including the development and validation of the MASCC COG-IMPACT. mascc.org/resources/asse…

COSA is pleased to endorse the Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations. bit.ly/44JLN0A Read the endorsement paper from Nicolas Hart and his co-authors at bit.ly/3GINjIi

#SuppOnc study in MASCC "Why stop therapy?" Research team discovers #diverse motivations ⭐️age 👵👴 ⭐️prognosis 🔮 ⭐️spirituality ⛪️ 🔑 for #personcentered care #pallonc 🔗: link.springer.com/article/10.100… Nicolas Hart Dr. Darren Haywood OncoAlert🚨 #OncoAlertAF